AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Dendritic cell vaccine generates anti-B16BL6 melanoma immunity in mice.

Vaccine Weekly

| November 19, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 NOV 19 - (NewsRx.com & NewsRx.net) -- Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.

"Dendritic cells (DCs) are the most potent professional antigen-presenting cells for the initiation of antigen-specific immune responses, and antigen-loaded DCs have been regarded as promising vaccines in cancer immunotherapy. We previously demonstrated that RGD fiber-mutant adenovirus vector (AdRGD) could attain highly efficient gene transduction into human and murine DCs. The aim of the present study is to demonstrate the predominance of ex vivo genetic DC manipulation using AdRGD in improving the efficacy of DC-based immunotherapy targeting gp100, a melanoma-associated antigen (MAA)," researchers in Japan report.

"Vaccination with murine bone marrow-derived DCs transduced with AdRGD encoding gp100 (AdRGD-gp100/mBM-DCs) dramatically improved resistance to B16BL6 melanoma challenge and pulmonary metastasis as compared with immunization with conventional Ad-gp100-transduced mBM-DCs," said N. Okada at Kyoto Pharmaceutical University and collaborators throughout Japan. "The improvement in antimelanoma effects upon immunization with AdRGD-gp100/mBM-DCs correlated with enhanced cytotoxic activities of natural killer (NK) cells and B16BL6-specific cytotoxic T lymphocytes (CTLs)."

...
Related articles from newspapers, magazines, journals, and more
Cytokine gene therapy staunches murine melanoma.
Newspaper article from: Cancer Gene Therapy Week April 12, 2004 700+ words
...net) -- Cytokine gene therapy staunches murine melanoma...mutant adenovirus vector (AdRGD) was a very useful vector...for in vivo cytokine gene therapy for established murine...intratumoral administration of AdRGD expressing tumor necrosis...
Gene therapy: science fiction or reality?
Magazine article from: Southern Medical Journal Preuss, Meredith A. Curiel, David T. January 1, 2007 700+ words
Gene therapy has been proposed to be the modern medical...mediator of behavior. In the early days of gene therapy, the primary purpose was to develop...associated with disease pathologies, gene therapy strategies have expanded to include...
Examine Gene Therapy Markets and Technologies Now!
Press release article from: Business Wire May 12, 2008 700+ words
...has announced the addition of "Gene Therapy - Technologies, Markets and Companies" to their offering. Gene therapy can be broadly defined as the transfer...genetically modified cells, the scope of gene therapy becomes much broader. Gene therapy...
Gene therapy industry should see brighter days.(Bruce A. Hironaka of Cell...
Magazine article from: San Diego Business Journal Webb, Marion November 16, 1998 700+ words
Today's gene therapy business looks "bleak," admits...opportunities at last week's third annual Gene Therapy and Genomics meeting at the Westin...There will be a significant demand for gene therapy," Hironaka said in a cheery introductory...
Gene therapy benefit said to outweigh risk.
News wire article from: United Press International October 10, 2002 700+ words
...International via COMTEX) The benefits of gene therapy far outweigh its risks and such procedures...emergency meeting Thursday to examine gene therapy safety issues following the report last...In addition, a clinical trial of gene therapy in France being conducted at the Hopital...
Research and Markets: Gene Therapy - Technologies, Markets and Companies.
Press release article from: PR Newswire March 10, 2005 700+ words
...c13775) has announced the addition of Gene Therapy - Technologies, Markets and Companies...bin/prnh/20040820/RESEARCH ) Gene therapy can be broadly defined as the transfer...genetically modified cells, the scope of gene therapy becomes much broader. Gene therapy...
Research and Markets: Gene Therapy - Technologies, Markets and Companies: New...
Press release article from: Business Wire April 28, 2004 700+ words
...com) has announced the addition of Gene Therapy - Technologies, Markets and Companies to their offering. Gene therapy can be broadly defined as the transfer...genetically modified cells, the scope of gene therapy becomes much broader. Gene therapy...
GENE THERAPY.
Magazine article from: The Exceptional Parent Meyers, Abbey S. March 1, 2000 700+ words
...1999, four days after receiving a gene therapy infusion at the University of Pennsylvania...first that could be directly linked to gene therapy--electrified the scientific community...have a powerful impact on the future of gene therapy experiments and how they are approved...
For more facts and information, see all results

Source: HighBeam Research, Dendritic cell vaccine generates anti-B16BL6 melanoma immunity in...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA